Skip to main content
Caplight Logo









Nanograb

Nanograb

Private
San Francisco, CaliforniaConsumer & Commercehttps://nanograb.com/

Last Round

Grant

Dec 13, 2023

Total Funding Raised

$500,000

Company Overview

Nanograb is a biotechnology company that develops a computational drug discovery platform using artificial intelligence to design targeted non-viral gene therapy vectors.

Sector

Consumer & Commerce

Verticals

Digital Advertising, Social Media, User-Generated Content

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

media downloadervideo converteronline video downloadersocial media downloadervideo grabberad-supported web utilityoffline video accessbrowser-based toolcomputational drug discoverybiotech R&Dgene therapy vectorsAI-driven drug discoverypeptide-decorated nanoparticles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanograb Comparables

Compare Nanograb with similar companies based on industry and business-model similarity.

No public comparables are available for Nanograb. Request access to learn about comparables coverage.

Request access

Nanograb Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 13, 2023
Pre SeedJul 1, 2023

Key People

Founding team and executive leadership

Debesh Mandal

Co-Founder and CEO

Founding Team

Nanograb Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 13, 2023

    Received funding from BlueYard Capital and Nucleate.

Nanograb Filings

Explore SEC and related filing metadata, where available.

Nanograb filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nanograb's valuation, stock price, and market status.

Is Nanograb a public or private company?

Nanograb is a private company.

What is the current stock price of Nanograb?

Nanograb is a private company with no public stock price. No recent secondary market data is available.

How much is Nanograb worth (valuation)?

Valuation information for Nanograb is not publicly available.

Can I buy Nanograb stock?

Nanograb shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nanograb's last funding round?

Nanograb's most recent funding round was Seed on July 1, 2023.

Who are the main investors in Nanograb?

Key investors in Nanograb include Recode Health Ventures, Imperial Enterprise Lab, Sterling Road, Y Combinator.

Will Nanograb IPO soon?

No public IPO plans have been announced for Nanograb.

How can I track Nanograb secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanograb's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2023
Last FundingDec 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?